Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 2
2004 13
2005 17
2006 15
2007 21
2008 13
2009 19
2010 35
2011 43
2012 50
2013 88
2014 98
2015 129
2016 134
2017 123
2018 151
2019 167
2020 215
2021 241
2022 313
2023 330
2024 347
2025 396
2026 83

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,685 results

Results by year

Filters applied: . Clear all
Page 1
New progress in HBV control and the cascade of health care for people living with HBV in China: evidence from the fourth national serological survey, 2020.
Hui Z, Yu W, Fuzhen W, Liping S, Guomin Z, Jianhua L, Feng W, Ning M, Jian L, Guowei D, Tongtong M, Lin T, Shuang Z, Mingshuang L, Yuan L, Xiaoqi W, Qianqian L, Qian Z, Dan W, Tingting Y, Qiudong S, Miao W, Li L, Qian H, Yixing L, Yi L, Shaodong Y, Zhijie A, Rodewald LE, Jidong J, Huaqing W, Wenzhou Y, Zhongfu L, Qun L, Zijian F, Zundong Y, Yu W. Hui Z, et al. Among authors: dan w. Lancet Reg Health West Pac. 2024 Sep 14;51:101193. doi: 10.1016/j.lanwpc.2024.101193. eCollection 2024 Oct. Lancet Reg Health West Pac. 2024. PMID: 39315090 Free PMC article.
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial.
Zhang X, Liang H, Li Z, Xue Y, Wang Y, Zhou Z, Yu J, Bu Z, Chen L, Du Y, Wang X, Wu A, Li G, Su X, Xiao G, Cui M, Wu D, Chen L, Wu X, Zhou Y, Zhang L, Dang C, He Y, Zhang Z, Sun Y, Li Y, Chen H, Bai Y, Wang Y, Yu P, Zhu G, Suo J, Jia B, Li L, Huang C, Li F, Ye Y, Xu H, Wang X, Yuan Y, E J, Ying X, Yao C, Shen L, Ji J. Zhang X, et al. Among authors: wu d. Lancet Oncol. 2025 Mar;26(3):312-319. doi: 10.1016/S1470-2045(24)00676-4. Epub 2025 Feb 11. Lancet Oncol. 2025. PMID: 39952264 Clinical Trial.
Tumor metastasis and recurrence: The role of perioperative NETosis.
Zeng F, Shao Y, Wu J, Luo J, Yue Y, Shen Y, Wang Y, Shi Y, Wu D, Cata JP, Yang S, Zhang H, Miao C. Zeng F, et al. Among authors: wu d. Cancer Lett. 2024 Dec 24;611:217413. doi: 10.1016/j.canlet.2024.217413. Online ahead of print. Cancer Lett. 2024. PMID: 39725150 Review.
2,685 results